Barinthus Biotherapeutics Plc Adr (BRNS)

Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025

Nov 15, 2024

New trial shows promise for chronic hepatitis B treatment - Investing.com India

Nov 15, 2024

Oct 01, 2024

Barinthus Bio completes enrollment for two clinical trials - Investing.com India

Oct 01, 2024

Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024

Sep 24, 2024

Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com

Sep 24, 2024

Sep 24, 2024

Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com

Sep 24, 2024

Sep 05, 2024

Barinthus Biotherapeutics appoints new COO - Investing.com

Sep 05, 2024

Sep 05, 2024

BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK

Sep 05, 2024

Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024

May 01, 2024

Kintara Therapeutics restructures share designations By Investing.com - Investing.com

May 01, 2024

Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024

Mar 13, 2024

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Mar 13, 2024

Apr 30, 2021

Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat

Apr 30, 2021

Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011